FIA
FCSC

FNY Investment Advisers’s Fibrocell Science Inc. FCSC Stock Holding History

FNY Investment Advisers’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,500
Closed -$8K – 1184
2018
Q3 		$8K Hold
3,500
– – ﹤0.01% 572
2018
Q2 		$9K Buy
+3,500
New +$10.1K ﹤0.01% 483

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

FNY Investment Advisers's FCSC Position: Q4 2018 in Review

FNY Investment Advisers sold out of Fibrocell Science Inc. (FCSC) in Q4 2018, closing a stake of 3,500 shares — an estimated $8K sold.

FNY Investment Advisers first reported a position in FCSC in Q2 2018 and held it in 2 quarters. The position peaked at $9K in Q2 2018. 26 funds tracked by Wall St. Rank hold FCSC as of Q4 2018.

  • FNY Investment Advisers reported no remaining Fibrocell Science Inc. position as of Q4 2018 after selling out during the quarter.
  • FNY Investment Advisers sold 3,500 Fibrocell Science Inc. shares in Q4 2018, an estimated $8K.
  • FNY Investment Advisers first reported a position in Fibrocell Science Inc. in Q2 2018 and held it in 2 quarters.
  • FNY Investment Advisers's Fibrocell Science Inc. position peaked at $9K in Q2 2018.
  • 26 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q4 2018.

Based on FNY Investment Advisers's 13F filing for Q4 2018, filed 22 Jan 2019.